Annual Accounts Receivable
$46.24 M
+$40.31 M+679.73%
December 31, 2024
Summary
- As of March 13, 2025, SWTX annual accounts receivable is $46.24 million, with the most recent change of +$40.31 million (+679.73%) on December 31, 2024.
- SWTX annual accounts receivable is now at all-time high.
Performance
SWTX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$46.24 M
+$13.27 M+40.23%
December 31, 2024
Summary
- As of March 13, 2025, SWTX quarterly accounts receivable is $46.24 million, with the most recent change of +$13.27 million (+40.23%) on December 31, 2024.
- Over the past year, SWTX quarterly accounts receivable has increased by +$21.73 million (+88.70%).
- SWTX quarterly accounts receivable is now at all-time high.
Performance
SWTX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
SWTX Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +679.7% | +88.7% |
| 3 y3 years | - | +88.7% |
| 5 y5 years | - | +88.7% |
SWTX Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | at high | -100.0% |
| 5 y | 5-year | at high | -100.0% | at high | -100.0% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
SpringWorks Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $46.24 M | $46.24 M(+40.2%) |
| Sep 2024 | - | $32.97 M(+34.6%) |
| Jun 2024 | - | $24.50 M(+57.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $15.53 M(+161.9%) |
| Dec 2023 | $5.93 M(>+9900.0%) | $5.93 M(>+9900.0%) |
| Dec 2022 | $0.00 | $0.00 |
FAQ
- What is SpringWorks Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for SpringWorks Therapeutics?
- What is SpringWorks Therapeutics annual accounts receivable year-on-year change?
- What is SpringWorks Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for SpringWorks Therapeutics?
- What is SpringWorks Therapeutics quarterly accounts receivable year-on-year change?
What is SpringWorks Therapeutics annual accounts receivable?
The current annual accounts receivable of SWTX is $46.24 M
What is the all time high annual accounts receivable for SpringWorks Therapeutics?
SpringWorks Therapeutics all-time high annual accounts receivable is $46.24 M
What is SpringWorks Therapeutics annual accounts receivable year-on-year change?
Over the past year, SWTX annual accounts receivable has changed by +$40.31 M (+679.73%)
What is SpringWorks Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of SWTX is $46.24 M
What is the all time high quarterly accounts receivable for SpringWorks Therapeutics?
SpringWorks Therapeutics all-time high quarterly accounts receivable is $46.24 M
What is SpringWorks Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, SWTX quarterly accounts receivable has changed by +$21.73 M (+88.70%)